Clinical Microbiology and Antimicrobial Chemotherapy. 2018; 20(1):24-34
The rapid spread of multidrug-resistant Gram-negative bacteria in hospital settings all over the world makes a demand for the new options to overcome antimicrobial resistance. Ceftazidime-avibactam is the first approved antibiotic that contains a new …